Cargando…

Induced pluripotent stem cells from Huntington’s disease patients: a promising approach to define and correct disease-related alterations

Detalles Bibliográficos
Autores principales:	Fatima, Azra, Gutiérrez-Garcia, Ricardo, Vilchez, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375035/ https://www.ncbi.nlm.nih.gov/pubmed/30688260 http://dx.doi.org/10.4103/1673-5374.249223

Ejemplares similares

Author Correction: The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington’s disease patients
por: Koyuncu, Seda, et al.
Publicado: (2020)

The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington’s disease patients
por: Koyuncu, Seda, et al.
Publicado: (2018)

Proteostasis of Huntingtin in Health and Disease
por: Koyuncu, Seda, et al.
Publicado: (2017)

G3BP1-dependent mechanism suppressing protein aggregation in Huntington’s models and its demise upon stress granule assembly
por: Gutiérrez-Garcia, Ricardo, et al.
Publicado: (2023)

Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine
por: Bono, Federica, et al.
Publicado: (2021)

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

Novel pluripotent stem cell lines for enriched grafting in Parkinson’s disease
por: Cota-Coronado, Agustin, et al.
Publicado: (2019)

Factors contributing to clinical picture and progression of Huntington's disease
por: Zielonka, Daniel
Publicado: (2018)

Striving for a Realistic and Unapologetic View of Huntington’s Disease
por: Serbin, Kenneth P.
Publicado: (2022)

Induced pluripotent stem cells are induced pluripotent stem cell-like cells
por: Song, Liting, et al.
Publicado: (2015)

Pluripotent stem cell derived inhibitory interneurons – principles and applications in health and disease
por: Keefe, Francesca, et al.
Publicado: (2019)

Putting the Brakes on Huntington Disease in a Mouse Experimental Model
por: Kim, Jane C., et al.
Publicado: (2015)

Histone methylation in Huntington’s disease: are bivalent promoters the critical targets?
por: Zsindely, Nóra, et al.
Publicado: (2018)

Hopping from One Cell to Another: Huntington's Disease Propagates
por: Park, Sang Myun
Publicado: (2017)

Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
por: Tousley, Adelaide, et al.
Publicado: (2016)

Somatic increase of CCT8 mimics proteostasis of human pluripotent stem cells and extends C. elegans lifespan
por: Noormohammadi, Alireza, et al.
Publicado: (2016)

Perspective on human pluripotent stem cell‐derived cardiomyocytes in heart disease modeling and repair
por: Li, Qiang, et al.
Publicado: (2020)

Renin-angiotensin system in the central nervous system: focus on Huntington’s disease
por: de Miranda, Aline Silva, et al.
Publicado: (2023)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
por: Bono, Federica, et al.
Publicado: (2017)

Turning Potential Into Action: Using Pluripotent Stem Cells to Understand Heart Development and Function in Health and Disease
por: Fonoudi, Hananeh, et al.
Publicado: (2017)

The Tumorigenic Potential of Human Pluripotent Stem Cells
por: Lezmi, Elyad, et al.
Publicado: (2022)

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Can leukocyte telomere shortening be a possible biomarker to track Huntington’s disease progression?
por: Mantuano, Elide, et al.
Publicado: (2019)

To Sleep to Dream … No More? The Quest for Restorative Sleep in Huntington’s Disease, a Clinician’s Perspective
por: Rosas, Herminia Diana
Publicado: (2023)

Suppression of SIRT2 and altered acetylation status of human pluripotent stem cells: possible link to metabolic switch during reprogramming
por: Kwon, Ok-Seon, et al.
Publicado: (2017)

Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research
por: Mascetti, Victoria L., et al.
Publicado: (2016)

Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells
por: Zhang, Ningzhe, et al.
Publicado: (2010)

Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons
por: Nekrasov, Evgeny D., et al.
Publicado: (2016)

Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington’s disease
por: Grice, Stuart J., et al.
Publicado: (2023)

Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease
por: Crane, Andrew T., et al.
Publicado: (2014)

A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells
por: Kurtz, Andreas, et al.
Publicado: (2018)

Transplantation of Induced Pluripotent Stem Cells Improves Functional Recovery in Huntington's Disease Rat Model
por: Mu, Shuhua, et al.
Publicado: (2014)

Regulation of one-carbon metabolism may open new avenues to slow down the initiation and progression of Huntington’s disease
por: Xie, Jiahua, et al.
Publicado: (2023)

Mitochondrial transplantation as a promising therapy for mitochondrial diseases
por: Zhang, Tian-guang, et al.
Publicado: (2023)

Promises and pitfalls of immune-based strategies for Huntington's disease
por: Colpo, Gabriela Delevati, et al.
Publicado: (2017)

Studying neurological disorders using induced pluripotent stem cells and optogenetics
por: Chin, Eunice W.M., et al.
Publicado: (2015)

On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2020)

Excitatory synapse impairment and mitochondrial dysfunction in Huntington’s disease: heat shock factor 1 (HSF1) converging mechanisms
por: Zarate, Nicole, et al.
Publicado: (2019)

Therapeutic potential of insulin-like growth factor 2 in Huntington’s disease: controlling proteostasis to alleviate the load of misfolded protein
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2021)

Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
por: Xu, Xiaohong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5g0f1c3jo3o44v42c4mo5nncrc